GB201007187D0 - Ubiquitination modulators - Google Patents
Ubiquitination modulatorsInfo
- Publication number
- GB201007187D0 GB201007187D0 GBGB1007187.6A GB201007187A GB201007187D0 GB 201007187 D0 GB201007187 D0 GB 201007187D0 GB 201007187 A GB201007187 A GB 201007187A GB 201007187 D0 GB201007187 D0 GB 201007187D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- ubiquitination
- modulators
- ubiquitination modulators
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1007187.6A GB201007187D0 (en) | 2010-04-29 | 2010-04-29 | Ubiquitination modulators |
PCT/GB2011/000658 WO2011135303A2 (en) | 2010-04-29 | 2011-04-28 | Ubiquitination modulators |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1007187.6A GB201007187D0 (en) | 2010-04-29 | 2010-04-29 | Ubiquitination modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201007187D0 true GB201007187D0 (en) | 2010-06-09 |
Family
ID=42271047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1007187.6A Ceased GB201007187D0 (en) | 2010-04-29 | 2010-04-29 | Ubiquitination modulators |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201007187D0 (en) |
WO (1) | WO2011135303A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX344555B (en) | 2007-05-08 | 2016-12-20 | Hunter Douglas Ind Switzerland | Multivariate color system with texture application. |
GB201007185D0 (en) | 2010-04-29 | 2010-06-09 | Iti Scotland Ltd | Ubiquitination assay |
BR102013022402B1 (en) * | 2013-09-02 | 2020-09-15 | Universidade Federal Do Rio Grande Do Sul | BENZYLTHIAZOLIDINONIC DERIVATIVES USEFUL IN TREATING SCHIZOPHRENIA |
CA2950354C (en) * | 2014-05-28 | 2023-10-03 | Universitat Bern | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders |
CN107089978A (en) * | 2016-02-17 | 2017-08-25 | 复旦大学 | Thiazolidinone derivatives and its production and use |
KR101940994B1 (en) | 2016-12-23 | 2019-01-23 | (주)위즈켐 | The preparation method of 4’-formyl-4-biphenylcarboxylic acid |
CN107383147A (en) * | 2017-07-14 | 2017-11-24 | 广东食品药品职业学院 | A kind of Sitosterolum and Epalrestat conjugate and its production and use |
CA3081553C (en) | 2017-11-17 | 2022-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of eye disorders |
PE20211001A1 (en) | 2018-02-27 | 2021-06-01 | Incyte Corp | IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS INHIBITORS OF A2A / A2B |
CA3093802A1 (en) | 2018-03-13 | 2019-09-19 | Shire Human Genetic Therapies, Inc. | Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof |
JP7391046B2 (en) | 2018-05-18 | 2023-12-04 | インサイト・コーポレイション | Fused pyrimidine derivatives as A2A/A2B inhibitors |
GEP20237560B (en) | 2018-07-05 | 2023-10-25 | Incyte Corp | Fused pyrazine derivatives as a2a / a2b inhibitors |
KR102348468B1 (en) * | 2018-08-30 | 2022-01-07 | 서울대학교산학협력단 | Human NADP-dependent steroid dehydrogenase-like (NSDHL) enzyme inhibitors and pharmaceutical composition for use in preventing or treating cancer or hypercholesterolemia containing the same as an active ingredient |
WO2020046020A1 (en) * | 2018-08-30 | 2020-03-05 | 서울대학교산학협력단 | Inhibitory material against human body-derived nicotinamide adenine dinucleotide phosphate-dependent steroid dehydrogenase-like, and anticancer agent comprising same as effective ingredient or pharmaceutical composition comprising same as effective ingredient for treatment of hyperlipidemia |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
TWI829857B (en) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | Pyrazolopyridines and triazolopyridines as a2a / a2b inhibitors |
EP4031547A1 (en) | 2019-09-18 | 2022-07-27 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof |
EP4031245A1 (en) | 2019-09-18 | 2022-07-27 | Takeda Pharmaceutical Company Limited | Heteroaryl plasma kallikrein inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6452014B1 (en) * | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
WO2005076695A2 (en) * | 2004-02-11 | 2005-08-25 | Painceptor Pharma Corporation | Methods of modulating neurotrophin-mediated activity |
US20050282818A1 (en) | 2004-06-22 | 2005-12-22 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
US20070099970A1 (en) * | 2005-08-19 | 2007-05-03 | Mackerell Alexander | Immunomodulatory compounds that target and inhibit the pY'binding site of tyrosene kinase p56 LCK SH2 domain |
-
2010
- 2010-04-29 GB GBGB1007187.6A patent/GB201007187D0/en not_active Ceased
-
2011
- 2011-04-28 WO PCT/GB2011/000658 patent/WO2011135303A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011135303A2 (en) | 2011-11-03 |
WO2011135303A3 (en) | 2012-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201007187D0 (en) | Ubiquitination modulators | |
DK3342786T3 (en) | Anti-dll3-antistof | |
AP3107A (en) | 5-Alkynyl-pyrimidines | |
EP2566479A4 (en) | Azaindazoles | |
EP2640189A4 (en) | 3-deutero-pomalidomide | |
DK3466977T3 (en) | Anti-vla-4-antistoffer | |
EP2651505A4 (en) | Electroporation-induced electrosensitization | |
EP2562212A4 (en) | Hydrogel | |
EP2641891A4 (en) | Pkc- activator | |
GB201001760D0 (en) | Dipenser | |
GB201001546D0 (en) | Knocktop | |
GB201001385D0 (en) | Cable-tidies | |
AU4536P (en) | TB01 Tibouchina urvilleana | |
AU4937P (en) | FlatinsulGL Myoporum insulare | |
AU4932P (en) | FlatwaxpinkGL Chamelaucium uncinatum | |
AU4822P (en) | FlatwaxwhiteGL Chamelaucium uncinatum | |
AU4931P (en) | FlatwaxDarkGL Chamelaucium uncinatum | |
TWM387087U (en) | can | |
GB201003529D0 (en) | eezy one | |
GB201022120D0 (en) | Wizz-through | |
AU2010194V (en) | CalpenGL Calothamnus quadrifidus | |
AU2010165V (en) | Silversunrise Conostylis candicans | |
GB201011766D0 (en) | Blocsock | |
GB201002838D0 (en) | Fireseal | |
GB201002840D0 (en) | Fireseal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |